It has been proposed that abnormal cytokine levels (e.g., IL-6 and TNF-α) are correlated with poor prognosis in SARS patients, and that the inhibitory effects of pentaglobin on cytokine release might represent an essential mechanism of action in the treatment of SARS (225, 235). This evidence concerns the gene TNF and severe acute respiratory syndrome.